NATICK, Mass. — Allurion Technologies, Inc. said it plans to appeal a notice from the New York Stock Exchange indicating the exchange intends to initiate delisting proceedings after the company failed to regain compliance with certain continued listing standards.
The NYSE notified the company that it had not satisfied Section 802.01B of the Listed Company Manual, which requires listed companies to maintain either at least $50 million in stockholders’ equity or at least $50 million in total market capitalization on a 30-trading day average basis. Allurion said it has the right to seek review of the determination by a committee of the NYSE’s board of directors.
The company said it intends to appeal the decision and expects its common stock to continue trading on the NYSE during the appeal process.
“We have been in regular contact with the NYSE about our step-by-step plan to regain compliance with its listing standards or initiate listing on the NYSE American,” said Dr. Shantanu Gaur, Founder and Chief Executive Officer. “The first step in our plan was receiving FDA approval on February 20, 2026. We believe this approval will catalyze the remaining parts of our plan to regain compliance or relist, and we expect our common stock to remain trading on the NYSE while we execute this plan.”
Allurion said its strategy to regain compliance with NYSE continued listing requirements, or to meet initial listing standards on another exchange, includes discussions and negotiations with existing creditors and security holders, as well as capital-raising efforts.
The company previously announced an agreement with its largest creditor to exchange outstanding debt securities for shares of preferred stock at an exchange ratio representing what it described as a substantial premium to its current trading price, subject to certain conditions. It also completed a warrant inducement transaction on February 24, 2026.
Allurion cautioned that there is no guarantee it will regain compliance and remain listed on the NYSE or secure a listing on another national exchange.
